Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
TWiV reviews results of a phase 3 trial of a self-amplifying mRNA COVID-19 vaccine, and the finding that baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology.
Hosts: Dickson Despommier, Alan Dove and Brianne Barker
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- MicrobeTV Discord Server
- MicrobeTV store at Cafepress
- Michelson Prizes: Next Generation Grants
- Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (Lancet Inf Dis)
- First self-amplifying mRNA vaccine approved in Japan (Science)
- Rise of the RNA machines (Trends Biochem)
- Innate and T cell populations correlates of protection against influenza (Nat Immunol)
- Timestamps by Jolene. Thanks!
Dickson - Nitrogen-fixing organelle in a marine algaBrianne – Mapping a lost branch of the Nile Alan – Interactive version of the updated USDA gardening zone map on NPR.
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]